These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
561 related articles for article (PubMed ID: 36481914)
1. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma. Liu Z; Meng X; Tang X; Zou W; He Y Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914 [TBL] [Abstract][Full Text] [Related]
2. Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV Li H; Zhu SW; Zhou JJ; Chen DR; Liu J; Wu ZZ; Wang WY; Zhang MJ; Sun ZJ J Dent Res; 2023 Jun; 102(6):678-688. PubMed ID: 36883630 [TBL] [Abstract][Full Text] [Related]
3. Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response. Sadeghirad H; Monkman J; Tan CW; Liu N; Yunis J; Donovan ML; Moradi A; Jhaveri N; Perry C; Adams MN; O'Byrne K; Warkiani ME; Ladwa R; Hughes BGM; Kulasinghe A J Transl Med; 2024 Jul; 22(1):677. PubMed ID: 39049036 [TBL] [Abstract][Full Text] [Related]
4. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma. Liang H; Zhang Z; Guan Z; Zheng S; Lou J; Liu W; Cai Q; Si Y Front Immunol; 2023; 14():1096220. PubMed ID: 36776859 [TBL] [Abstract][Full Text] [Related]
5. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer. An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD Front Immunol; 2022; 13():1049884. PubMed ID: 36420257 [TBL] [Abstract][Full Text] [Related]
6. Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8 Wang M; Zhai R; Wang M; Zhu W; Zhang J; Yu M; Zhang W; Ye J; Liu L Mol Oncol; 2023 Aug; 17(8):1514-1530. PubMed ID: 36825382 [TBL] [Abstract][Full Text] [Related]
7. Tertiary Lymphoid Structures Gene Signature Predicts Prognosis and Immune Infiltration Analysis in Head and Neck Squamous Cell Carcinoma. Xing A; Lv D; Wu C; Zhou K; Zhao T; Zhao L; Wang H; Feng H Curr Genomics; 2024 Apr; 25(2):88-104. PubMed ID: 38751598 [TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma. Yao Y; Xuan H; Wang J; Gong L; Gao W Tumori; 2023 Oct; 109(5):466-480. PubMed ID: 37249074 [TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma. Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038 [TBL] [Abstract][Full Text] [Related]
10. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer. Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y Front Immunol; 2022; 13():868155. PubMed ID: 35664009 [TBL] [Abstract][Full Text] [Related]
11. A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy. Li X; Wan Z; Liu X; Ou K; Yang L Med Oncol; 2022 Jan; 39(4):43. PubMed ID: 35092511 [TBL] [Abstract][Full Text] [Related]
12. Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma. Zhang B; Li H; Liu YT; Xiong D; Zhang L; Sun ZJ Cancer Lett; 2023 Apr; 558():216105. PubMed ID: 36841416 [TBL] [Abstract][Full Text] [Related]
13. CXC ligand 13 orchestrates an immunoactive microenvironment and enhances immunotherapy response in head and neck squamous cell carcinoma. Lin X; Zhao X; Chen Y; Yang R; Dai Z; Li W; Lin C; Cao W Int J Immunopathol Pharmacol; 2024; 38():3946320241227312. PubMed ID: 38252495 [No Abstract] [Full Text] [Related]
14. The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancer. Weng Y; Yuan J; Cui X; Wang J; Chen H; Xu L; Chen X; Peng M; Song Q Sci Rep; 2024 Jul; 14(1):16246. PubMed ID: 39009684 [TBL] [Abstract][Full Text] [Related]
15. HLA-A Zhang D; Jiang D; Jiang L; Ma J; Wang X; Xu X; Chen Z; Jiang M; Ye W; Wang J; Meng W; Qiu W; Hou Y; Huang J; Jiao Y; Liu Y; Liu Z Br J Cancer; 2024 Jul; 131(1):184-195. PubMed ID: 38762674 [TBL] [Abstract][Full Text] [Related]
16. Tertiary lymphoid structures in the era of cancer immunotherapy. Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904 [TBL] [Abstract][Full Text] [Related]
17. Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma. Secrier M; McGrath L; Ng F; Gulati S; Raymond A; Nuttall BRB; Berthe J; Jones EV; Sidders BS; Galon J; Barrett JC; Angell HK Cancer Res Commun; 2023 Oct; 3(10):2133-2145. PubMed ID: 37819239 [TBL] [Abstract][Full Text] [Related]
18. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy. Zou X; Guan C; Gao J; Shi W; Cui Y; Zhong X Front Immunol; 2023; 14():1222719. PubMed ID: 37529035 [TBL] [Abstract][Full Text] [Related]
19. Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma. Bao J; Betzler AC; Hess J; Brunner C Front Immunol; 2023; 14():1233085. PubMed ID: 37868967 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma. Li Q; Liu X; Wang D; Wang Y; Lu H; Wen S; Fang J; Cheng B; Wang Z Int J Oral Sci; 2020 Sep; 12(1):24. PubMed ID: 32934197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]